Cefpodoxime Proxetil Tablet, Film Coated
Product Images NDC 51407-083

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefpodoxime Proxetil (NDC 51407-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefpodoxime-structure (Cefpodoxime Structure)

Chemical structure of the active ingredient Cefpodoxime Proxetil, illustrating its molecular composition and arrangement of atoms.*

FDA Label Image

Pl (51407-083-20)

Label for Cefpodoxime Proxetil Tablets, USP, 100 mg strength, film-coated tablets, oral route. The label indicates 20 tablets per container. It is marketed by GSMS, Incorporated, Camarillo, CA, USA and manufactured by Alkem Laboratories Ltd., India. The label includes storage instructions, dosage reference, and safety warnings for child safety, along with an NDC number 51407-083-20 and a barcode.*

FDA Label Image

Pl (51407-084-20)

Label for Cefpodoxime Proxetil 200 mg film-coated tablets, USP, manufactured by Alkem Laboratories Ltd., India, and marketed by GSMS, Incorporated, Camarillo, CA. The label indicates a package of 20 tablets with the NDC 51407-084-20. Additional storage and handling instructions are provided, along with a barcode and branding elements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.